-
Recent Posts
- Dementia-Friendly Communities Provision, Viewed as a Social Determinant of Health (JGCR / NHS England / WHO)
- International Perspectives on the Possible Impact of the COVID-19 Pandemic and Lockdown on Abuse of the Elderly (JGCR / American Journal of Geriatric Psychiatry / JAGS)
- Updates Relating to the Lancet Commission on Dementia Prevention, Intervention, and Care (Lancet / Alzheimer’s Research and Therapy / Alzheimer’s and Dementia)
- A Brief Review of How the COVID-19 Pandemic Relates to Elderly Care and Research (JGCR)
- Some Speculated / Potential Benefits of COVID-19 (JGCR / BBC Radio 4’s Rethink / BGS)
Archives
- September 2020
- August 2020
- June 2020
- April 2020
- March 2020
- February 2020
- January 2020
- December 2019
- November 2019
- October 2019
- September 2019
- August 2019
- July 2019
- June 2019
- May 2019
- April 2019
- March 2019
- February 2019
- January 2019
- December 2018
- November 2018
- October 2018
- September 2018
- August 2018
- July 2018
- June 2018
- May 2018
- April 2018
- March 2018
- February 2018
- January 2018
- December 2017
- November 2017
- October 2017
- September 2017
- August 2017
- July 2017
- June 2017
- May 2017
- April 2017
- March 2017
- February 2017
- January 2017
- December 2016
- November 2016
- October 2016
- September 2016
- August 2016
- July 2016
- June 2016
- May 2016
- April 2016
- March 2016
- February 2016
- January 2016
- December 2015
- November 2015
- October 2015
- September 2015
- August 2015
- July 2015
- June 2015
- May 2015
- April 2015
- March 2015
- February 2015
- January 2015
- December 2014
- November 2014
- October 2014
- September 2014
- August 2014
- July 2014
- June 2014
- May 2014
- April 2014
- March 2014
- February 2014
- January 2014
- December 2013
- November 2013
- October 2013
- September 2013
- August 2013
- July 2013
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
Categories
- Antipsychotics
- Assistive Technology
- Charitable Bodies
- Commissioning
- Delirium
- Depression
- Enhancing the Healing Environment
- Falls
- Falls Prevention
- Guidelines
- Hip Fractures
- Housing
- Hypertension
- In the News
- Integrated Care
- International
- Local Interest
- Mental Health
- Models of Dementia Care
- National
- ADASS
- All-Party Parliamentary Group (APPG) on Dementia
- BSI
- CQC: Care Quality Commission
- Department of Health
- Department of Health and Social Care (DHSC)
- Health Education England (HEE)
- Housing LIN
- MAGDR
- Mental Health Foundation
- Mental Health Network (NHS Confederation)
- MHP Health Mandate
- National Audit Office
- National Voices
- NEoLCIN
- NEoLCP
- NHS
- NHS Alliance
- NHS Confederation
- NHS Employers
- NHS England
- NHS Evidence
- NHS Improvement
- NICE Guidelines
- NIHR
- NIHRSDO
- Northern Ireland
- Patients Association
- Public Health England
- RCN
- Royal College of Physicians
- Royal College of Psychiatrists
- SCIE
- Scotland
- UK
- UK NSC
- Wales
- Non-Pharmacological Treatments
- Nutrition
- Pain
- Parkinson's Disease
- Patient Care Pathway
- Person-Centred Care
- Personalisation
- Pharmacological Treatments
- Proposed for Next Newsletter
- Quick Insights
- Standards
- Statistics
- Stroke
- Systematic Reviews
- Telecare
- Telehealth
- Universal Interest
Google Translate (100+ Languages)
Tag Archives: Antipsychotics-Related Mortality Risks
NICE Update on Antipsychotics for People With Dementia (NICE)
Summary The National Institute for Health and Care Excellence (NICE) has again updated their summary of evidence on the use (or withdrawal) of antipsychotics for people living with dementia. This document is not a formal NICE guideline. Full Text Link … Continue reading →
Posted in Acute Hospitals, Antipsychotics, Commissioning, Community Care, Falls Prevention, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), Integrated Care, Management of Condition, Mental Health, Models of Dementia Care, National, Non-Pharmacological Treatments, Person-Centred Care, Pharmacological Treatments, Quick Insights, SCIE, Systematic Reviews, UK, Universal Interest
|
Tagged Alive Approach to Provision of Meaningful Activities for Older People Living in Care, Alternatives to Antipsychotic Drugs, Alternatives to Antipsychotic Medication, Antipsychotic Drugs, Antipsychotic Prescribing in Primary Care, Antipsychotics, Antipsychotics and Risk of Venous Thromboembolism, Antipsychotics in Elderly People with Dementia, Antipsychotics in People With Dementia, Antipsychotics in People With Dementia: Key Therapeutic Topic [KTT7], Antipsychotics Limitation in Dementia, Antipsychotics-Related Mortality Risks, Atypical Antipsychotics, Avoidable Harm, Avoidable Mortality, Behavioural and Psychological Symptoms of Dementia (BPSD), Inappropriate Use of Antipsychotics in Dementia, Later Life, Long Term Plan (LTP), Medicines Optimisation, Mellifont Abbey Residential Care Home, Mental Health and Illness, Milton Keynes Primary Care Trust, National Institute for Health and Care Excellence (NICE), National Institute for Health and Care Excellence (NICE)’s Quality Standard on Dementia: 2019 Draft For Consultation, Neurological Disorders, NHS England Medicines Optimisation Intelligence Group, NICE Key Therapeutic Topic [KTT7], NICE Key Therapeutic Topics, Potential Harms of Antipsychotic Use, Prescribing of Antipsychotic Drugs For People With Dementia, Prevalence of Potentially Inappropriate Prescribing of Antipsychotic Drugs, Reducing Antipsychotic Prescriptions in Dementia, Reducing Inappropriate Use of Antipsychotics in Dementia, Social Care Institute for Excellence (SCIE)
|
Leave a comment
Update to Evidence on Antipsychotics in People With Dementia (NICE)
Summary The National Institute for Health and Care Excellence (NICE) has published an updated summary of the evidence on safer use (or withdrawal) of antipsychotics for people living with dementia. This document is not a formal NICE guideline. Full Text … Continue reading →
Posted in Acute Hospitals, Antipsychotics, Commissioning, Community Care, Falls Prevention, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), Integrated Care, Management of Condition, Mental Health, Models of Dementia Care, National, Non-Pharmacological Treatments, Person-Centred Care, Pharmacological Treatments, Quick Insights, SCIE, Systematic Reviews, UK, Universal Interest
|
Tagged Alternatives to Antipsychotic Drugs, Alternatives to Antipsychotic Medication, Antipsychotic Drugs, Antipsychotic Prescribing in Primary Care, Antipsychotics, Antipsychotics and Risk of Venous Thromboembolism, Antipsychotics in Elderly People with Dementia, Antipsychotics in People With Dementia, Antipsychotics in People With Dementia: Key Therapeutic Topic [KTT7], Antipsychotics Limitation in Dementia, Antipsychotics-Related Mortality Risks, Atypical Antipsychotics, Avoidable Harm, Avoidable Mortality, Behavioural and Psychological Symptoms of Dementia (BPSD), Inappropriate Use of Antipsychotics in Dementia, Later Life, Medicines Optimisation, Mental Health and Illness, National Institute for Health and Care Excellence (NICE), Neurological Disorders, NHS England Medicines Optimisation Intelligence Group, NICE Key Therapeutic Topic [KTT7], NICE Key Therapeutic Topics, Potential Harms of Antipsychotic Use, Prescribing of Antipsychotic Drugs For People With Dementia, Prevalence of Potentially Inappropriate Prescribing of Antipsychotic Drugs, Reducing Antipsychotic Prescriptions in Dementia, Reducing Inappropriate Use of Antipsychotics in Dementia, Social Care Institute for Excellence (SCIE)
|
Leave a comment
Review of Non-Pharmacological Interventions for Dementia-Related Agitation: Including a Brief Analysis of the Risks and Benefits of Drug Treatments (Translational Psychiatry)
Summary A recently published literature review evaluates the best available evidence on the effectiveness of various non-pharmacological interventions for reducing dementia-related agitation. The author also briefly addresses current viewpoints on balancing the risks and benefits of pharmacotherapy in the management … Continue reading →
Posted in Acute Hospitals, Antipsychotics, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), Local Interest, Management of Condition, Mental Health, Models of Dementia Care, New Cross Hospital, Non-Pharmacological Treatments, Person-Centred Care, Personalisation, Pharmacological Treatments, Quick Insights, Royal Wolverhampton NHS Trust, Royal Wolverhampton NHS Trust Authorial Affiliation, Systematic Reviews, UK, Universal Interest, Wolverhampton
|
Tagged ACADIA Pharmaceuticals, Agitation, Agitation and Aggression, Alternatives to Antipsychotic Drugs, Animal Assisted Therapy, Antipsychotics, Antipsychotics and Risk of Venous Thromboembolism, Antipsychotics in Elderly People with Dementia, Antipsychotics Limitation in Dementia, Antipsychotics-Related Mortality Risks, Aromatherapy, Arts and Music in Dementia, Atypical Antipsychotics, Avanir Pharmaceuticals Inc (California), Behavioural Alternatives to Antipsychotic Drugs, Behavioural and Psychological Symptoms of Dementia (BPSD), Behavioural Problems, Behavioural Problems in People With Dementia, Behavioural Variant Frontotemporal Dementia (bvFTD), BPSD, BPSD: Behavioral and Psychological Symptoms of Dementia, Carbamazepine, Citalopram, Citalopram for Agitation in Alzheimer's Disease: CitAD Trial, Cognitive Behavioral Therapy, Dementia-Related Agitation, Department of Medicine: Royal Wolverhampton NHS Trust, Describe Investigate Create and Evaluate (DICE) Approach, East Kent Hospitals University NHS Foundation Trust, Electroconvulsive Therapy for Agitation and Aggression in Dementia, Improving the Quality of Life for People With Dementia, Interventions for BPSD, Intra-Cellular Therapies, Medication-Related Risks, Medications: Best Usage, Medicines Optimisation, Memantine, Mirtazapine, Mood Disturbances, Multisensory Stimulation, Music Therapy, Music Therapy for BPSD, Music-Based Therapeutic Interventions, Nature Publishing Group, Neuroleptic Discontinuation, Neuroleptics, Neuropsychiatric Symptoms (NPS), Neuropsychiatric Symptoms in People With Dementia, Non-Pharmacological Management of Symptoms, Non-Pharmacological Treatments, Otsuka Pharmaceuticals Limited, Pharmacological Treatments, Potential Harms of Antipsychotic Use, Potentially Inappropriate Medications (PIM), Potentially Inappropriate Prescribing (PIP), Potentially Inappropriate Prescribing in Advanced Dementia, Prescribing of Antipsychotic Drugs For People With Dementia, Quetiapine, Reducing Inappropriate Use of Antipsychotics in Dementia, Risperidone, Simulated Presence Therapy (SPT), Simulated Presence Therapy for BPSD, Targeted Interdisciplinary Model for Evaluation and Treatment of Neuropsychiatric Symptoms (TIME), Translational Psychiatry, Withdrawal of Neuroleptic Medications
|
Leave a comment
National Prevention Concordat for Better Mental Health (PHE / King’s Fund / LSE PSSRU / UCL / CfMH / British Journal of Psychiatry / BBC News)
Summary Public Health England (PHE) has released a collection of related documents aimed primarily at local public health workers, designed to help identify cost-effective local mental health interventions. This new “concordat” tool aims to prevent mental health problems (a Five … Continue reading →
Posted in Commissioning, Community Care, Depression, For Doctors (mostly), For Researchers (mostly), For Social Workers (mostly), Guidelines, In the News, Integrated Care, King's Fund, Local Interest, Management of Condition, Mental Health, National, NHS, Non-Pharmacological Treatments, Person-Centred Care, Public Health England, Quick Insights, Standards, Statistics, UK, Universal Interest
|
Tagged Abigail Gallop: Local Government Association, About the Mental Health and Wellbeing JSNA Knowledge Guide, Addressing Loneliness to Protect the Mental Health of Older People, Affluence and Health Inequalities, Ageing Population, Alexandra Lazaro: Department of Health, Andrew Furber: President of Association of Directors of Public Health UK, Andrew Herd: Policy Lead for Five Year Forward View for Mental Health and Cross-Government Strategy / Suicide & Self-Harm Prevention at Department of Health, Andy Bell: Deputy Chief Executive at Centre for Mental Health, Antipsychotic Drugs, Antipsychotics Side Effects, Antipsychotics-Related Mortality Risks, Assaults on Mental Health Staff, Association of Directors of Public Health UK, Association of Mental Health Providers, Attitudes to Mental Illness, Barriers and Facilitators in Commissioning of Services for Preventing Mental Ill-Health, Barriers and Facilitators in Commissioning of Services for Promotion of Mental Health and Wellbeing, BBC 5 Live, BBC Health News, BBC Radio 5 Live, BBC Radio 5 Live Investigates, Better Mental Health - Joint Strategic Needs Assessment (JSNA) Toolkit: Children and Young People, Better Mental Health - Joint Strategic Needs Assessment (JSNA) Toolkit: Living Well in Older Years, Better Mental Health - Joint Strategic Needs Assessment (JSNA) Toolkit: Perinatal Mental Health, Better Mental Health - Joint Strategic Needs Assessment (JSNA) Toolkit: Understanding People, Better Mental Health - Joint Strategic Needs Assessment (JSNA) Toolkit: Understanding Place, Better Mental Health - Joint Strategic Needs Assessment (JSNA) Toolkit: Working Age Adults, Better Mental Health - Joint Strategic Needs Assessment (JSNA) Toolkit:Perinatal Mental Health, Better Mental Health for All, Brian Ferguson: Public Health England, British Journal of Psychiatry, Cam Lugton: National Mental Health Dementia and Neurology Intelligence Network at Public Health England, Catherine Newsome: Department of Education, Centre for Mental Health, Centre for Mental Health (Faculty of Medicine: Imperial College), Changing Attitudes to Mental Illness, Chartered Institute of Personnel and Management, Children and Young People (CYP), Children and Young People’s Mental Health, Children and Young Peoples Mental Health Coalition, Christina Gray: Chair of Public Mental Special Interest Group at Faculty of Public Health, Claire Murdoch: Chair of Mental Health and Dementia Programme Board, Claire Murdoch: NHS England’s National Director for Mental Health, Common Mental Disorders: Statistics By Sex, Community Mental Health Needs Assessments, Corinne Harvey: Public Health England, Costs of Mental Health Problems at Work, Coventry Acting Early Programme, Coventry City Council, Debt Advice to Protect Mental Health, Department of Psychology: King’s College London, Department of Psychosis Studies: King's College London, Detentions Under the Mental Health Act in England (April 2014 to March 2015), Determinants of Mental Health, Dr Geraldine Strathdee: National Clinical Lead of Mental Health Intelligence Network at Public Health England, Epidemiology and Statistics, Faculty of Public Health (FPH), Fit Notes (Mental Health Problems), Great Britain Suicide Rates: By Sex, Gregor Henderson: National Lead for Mental Health and Wellbeing at Public Health England, Health Inequalities, Health Inequalities in England, Hertfordshire County Council, Improving Life Expectancy in People With Serious Mental Illness (Role of Primary Prevention), Improving Perinatal Mental Health, Inequalities in Health Outcomes, Institute of Health Equity, Institute of Health Equity (UCL), Institute of Psychiatry Psychology and Neuroscience: King’s College London, Isabella Goldie: Mental Health Foundation, Jed Boardman: Royal College of Psychiatrists, Jim McManus: Public Mental Health Lead at Association of Directors of Public Health, Joint Strategic Needs Assessment (JSNA), Journal of Geriatric Care and Research (JGCR), JSNAs: Joint Strategic Needs Assessments, Kathy Roberts: Chief Executive at Association of Mental Health Providers, Kings College London, LGA: Local Government Association, Life Course Approach, Life Course Approaches to Prevention and Care, Lily Makurah: Deputy National Lead for Public Mental Health at Public Health England, Living Well in Older Years (Better Mental Health), Local Action on Health Inequalities, Local Area Coordination, Local Context, Local Government Association, Local Mental Health Services, London School of Economics and Political Science (LSE), Loneliness and Social Isolation, Mental Health and Wellbeing, Mental Health and Wellbeing in the Workplace, Mental Health and Wellbeing Joint Strategic Needs Assessment (JSNA) Profile(s), Mental Health and Wellbeing Joint Strategic Needs Assessment Toolkit / Knowledge Guide, Mental Health and Wellbeing JSNA Fingertips Profiles, Mental Health Commissioners Network / NHS Clinical Commissioners, Mental Health Commissioners Network of NHS Clinical Commissioners, Mental Health Foundation (MHF), Mental Health Inequalities, Mental Health Needs Assessment, Mental Health of People With Long-term Physical Health Problems, Mental Health Problems at Work, Mental Health Promotion: Return on Investment Tool, Mental Health Services: Cost-Effective Commissioning, Mental Health Staff: Long-Term Stress Leave, Mental Health: Epidemiology and Statistics, Mental Health: Ten Charts (BBC News), Mental Wellbeing Impact Assessment (MWIA) Tool, Michael Streather: Head of Mental Health Intelligence Network at Public Health England, Mick Atkinson: Former Vice Chair of Children and Young Peoples Mental Health Coalition, Minding Health (Training Programme), Multi-Agency Suicide Prevention, Multisectoral Collaboration, National Mental Health Dementia and Neurology Intelligence Network (NMHDNIN), National Mental Health Intelligence Network (NMHIN), National Prevention Concordat for Better Mental Health (PHE), National Suicide Prevention Strategy, National Survivor User Network, Needs and Assets Assessment, Needs Assessments, NHS Digital, NHS Digital (Formerly the Health and Social Care Information Centre), NHS Mental Health Staff: Sick Leave, NMHDNIN: National Mental Health Dementia and Neurology Intelligence Network, North West London: Like Minded Programme, Nutritional and Metabolic Disorders, Out of Area Placements (OAPs), Panos Zerdevas: Public Health England, Partnership and Alignment, Perinatal Mental Health, PHE: Public Health England, Phil Moore Chair, Phoebe Robinson: Head of Mental Health (Clinical Policy and Strategy) at NHS England, Physical Health Monitoring, Presenteeism, Prevention, Prevention Agenda, Prevention Concordat (PHE), Prevention Concordat For Better Mental Health (PHE; August 2017), Prevention Concordat for Better Mental Health: Prevention Planning, Prevention Through Identifying and Addressing Causes in Local Areas (JSNAs), Primary Prevention, Primary Prevention Interventions, Problem Debt, Problem Debt and Mental Health, Psychosocial Pathway (UCL), Psychosocial Pathways and Health Outcomes / Inequalities, Psychosocial Pathways to Health Inequalities, Psychosocial Pathways to Mental Health Inequalities, Public Health Approach to Mental Health Improvement, Public Health England (PHE), Public Mental Health, Public Mental Health Commissioning, Public Mental Health Leadership and Workforce Development Framework, Public Mental Health Leadership and Workforce Development Framework Call to Action, Public Mental Health Priorities, Public Mental Health Strategy for Southampton: Be Well, Reducing Inappropriate Use of Antipsychotics, Reducing the Use of Police Cells, Return on Investment, Return on Investment: Cost-Effective Commissioning of Local Mental Health Services, Risk and Supporting Factors for Mental Health, Routine Enquiry About Adversity in Childhood (REACh) Intervention, Royal College of Psychiatrists Workforce Census 2017, Sandwell Council, Sandwell Model for Reducing Health Inequalities, Sarah Yiannoullou: National Survivor User Network, School-Based Social and Emotional Learning Programmes, Secondary Prevention, Severe Mental Illness (SMI), Severe Mental Illness Increases Since Early 1990s, Social Determinants of Health, Social Determinants of Health Inequalities, Social Determinants of Mental Health, Social Determinants of Mental Health and Mental Health Inequalities, Social Equity, South London and the Maudsley NHS Foundation Trust, Southampton City Council, Southern Health NHS Trust, Staff Absenteeism, Staff Turnover, State of Mind: BBC 5 Live's Mental Health Season, Stress, Suicide and Self-Harm Prevention, Suicide Prevention, Tackling Inequalities, Tackling Stigma and Improving Attitudes to Mental Illness, Tertiary Prevention, Thrive London, Transferable Effective Practice., UCL Institute of Health Equity, University College London Institute of Health Equity, Unmet Mental Health Needs, Unmet Mental Health Needs of Older People, Warrington, WarwickEdinburgh Mental Well-being Scale, Warwickshire County Council, Whole Population Approachess, Wider Determinants of Mental Health, Working Age Adult (WAA), Working Age Adults, Working Age Population, Workplace Interventions to Prevent Stress Depression and Anxiety, Workplace Prevention of Mental Health Problems
|
Leave a comment
Historic Reduction in the Use of Antipsychotics for BPSD in UK General Practice? (Drug Safety)
Summary Data from 111,346 patients with dementia but without a concomitant diagnosis of psychosis indicates that prescribing of certain categories of antipsychotic drugs did reduce from 8.9% in 2001 to 1.4% in 2014. At face value, this reduction in inappropriate … Continue reading →
Posted in Antipsychotics, Commissioning, Community Care, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), Management of Condition, Mental Health, Models of Dementia Care, National, NICE Guidelines, Person-Centred Care, Pharmacological Treatments, Quick Insights, Standards, Statistics, UK
|
Tagged Alistair Burns: NHS England’s National Clinical Director for Dementia, Alistair Burns: NHS England’s National Clinical Director for Older People’s Mental Health, Alistair Burns: Professor of Old Age Psychiatry at University of Manchester, Alternatives to Antipsychotic Drugs, Alternatives to Antipsychotic Medication, Amisulpride, Antipsychotic Drugs, Antipsychotic Prescribing in Primary Care, Antipsychotics, Antipsychotics and Risk of Venous Thromboembolism, Antipsychotics in Elderly People with Dementia, Antipsychotics Limitation in Dementia, Antipsychotics-Related Mortality Risks, Atypical Antipsychotics, Avoidable Harm, Avoidable Mortality, Behavioural and Psychological Symptoms of Dementia (BPSD), Centre for Health Informatics: University of Manchester, Centre for Pharmacoepidemiology and Drug Safety: University of Manchester, Centre for Primary Care (University of Manchester), Clinical Practice Research Datalink (CPRD), Discontinuation of Antipsychotics, Division of Informatics Imaging and Data Sciences: University of Manchester, Division of Neuroscience and Experimental Psychology: University of Manchester, Division of Pharmacy and Optometry: University of Manchester, Division of Population Health Health Services Research and Primary Care: University of Manchester, Division of Primary Care: University of Manchester, Division of Psychology and Mental Health: University of Manchester, Drug Safety (Journal), English National Dementia Strategy, First-Generation Antipsychotic Drugs, General Practice, Inappropriate Use of Antipsychotics in Dementia, Longitudinal Changes in Inappropriate Prescribing, Manchester, Manchester Academic Health Sciences Centre, MHRA Committee for the Safety of Medicines, National Dementia Challenge, National Dementia Strategy, National Institute for Health Research Greater Manchester Primary Care Patient Safety Translational Research Centre: University of Manchester, Neuroleptic Discontinuation, Neuroleptics, Olanzapine, Potential Harms of Antipsychotic Use, Prescribing of Antipsychotic Drugs For People With Dementia, Prevalence of Potentially Inappropriate Prescribing of Antipsychotic Drugs, Prime Minister’s Dementia Challenge, Professor Alistair Burns, Psychological Symptoms of Dementia (BPSD), Queen's Medical Centre: University of Nottingham, Quetiapine, Reducing Antipsychotic Prescriptions in Dementia, Reducing Inappropriate Use of Antipsychotics in Dementia, Risperidone, School of Biological Sciences: University of Manchester, School of Health Sciences: University of Manchester, School of Medicine: University of Nottingham, Second-Generation Antipsychotic Drugs, Temporal Changes in Prescribing of Antipsychotic Drugs from 2001 to 2014, University of Manchester, University of Nottingham, Use of Antipsychotics for BPSD in UK General Practice
|
Leave a comment
Immovable Antipsychotic Prescribing Practices in Care Homes? (BMJ Open)
Summary Incredible as it may seem, and contrary to years of high-level campaigning plus the circulation of awareness raising reports and guidelines, antipsychotic prescribing in long-term residential care in England did not, in fact, decline measurably during the four years … Continue reading →
Posted in Antipsychotics, Commissioning, Community Care, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), In the News, International, Management of Condition, Mental Health, Models of Dementia Care, Pharmacological Treatments, Quick Insights, Standards, Statistics, UK, Universal Interest
|
Tagged Alternatives to Antipsychotic Drugs, Alternatives to Antipsychotic Medication, Antipsychotic Drugs, Antipsychotic Prescribing in Care Homes, Antipsychotics, Antipsychotics and Risk of Venous Thromboembolism, Antipsychotics in Elderly People with Dementia, Antipsychotics Limitation in Dementia, Antipsychotics-Related Mortality Risks, Atypical Antipsychotics, Avoidable Harm, Avoidable Mortality, Behavioural and Psychological Symptoms of Dementia (BPSD), BMJ Open, BMJ Publishing Group Ltd, BPSD, BPSD: Behavioral and Psychological Symptoms of Dementia, City University London, Coventry, Coventry University, Department Mathematics and Statistics: Lancaster University, Discontinuation of Antipsychotics, English National Dementia Strategy, Faculty of Health and Life Sciences: Coventry University, Inappropriate Use of Antipsychotics in Dementia, Institute for Employment Research: University of Warwick, Invatech Health Ltd, Lancaster, Lancaster University, Management of Medicines, National Dementia Strategy, Neuroleptic Discontinuation, Neuroleptics, Norwich Medical School: University of East Anglia, Potential Harms of Antipsychotic Use, Prescribing of Antipsychotic Drugs For People With Dementia, Psychological Symptoms of Dementia (BPSD), Qualitative Research, Reducing Antipsychotic Prescriptions in Dementia, Reducing Inappropriate Use of Antipsychotics in Dementia, School of Health Sciences: City University London, University of East Anglia, University of Warwick, Withdrawal of Neuroleptic Medications
|
1 Comment
Introducing the Journal of Geriatric Care and Research (JGCR)
Summary The Journal of Geriatric Care and Research (ISSN 2397-5628) is a recently launched, locally edited, multi-disciplinary peer-reviewed international journal, which covers topics of relevance to the care of the elderly. Concerning Guidelines on the Use of Antipsychotics for Agitation … Continue reading →
Posted in Acute Hospitals, Antipsychotics, Community Care, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), Guidelines, International, Local Interest, Management of Condition, Mental Health, Models of Dementia Care, Person-Centred Care, Pharmacological Treatments, Quick Insights, Wales, Wolverhampton
|
Tagged Academia.edu, Adverse Drug Reactions (ADRs), Adverse Drug Reactions in the Elderly, Adverse Effects, Aggression, Aggressive Behaviour, Agitation, Agitation and Aggression, Alternatives to Antipsychotics, Alzheimer’s Disease-Related Agitation, American Journal of Psychiatry, American Psychiatric Association (APA), American Psychiatric Association: Practice Guideline on the Use of Antipsychotics to Treat Agitation or Psychosis in Patients With Dementia (2016), Antipsychotic Drugs, Antipsychotics, Antipsychotics and Risk of Venous Thromboembolism, Antipsychotics Limitation in Dementia, Antipsychotics Side Effects, Antipsychotics-Related Mortality Risks, Antipsychotics: Neuroleptic Sensitivity, APA Practice Guidelines, Aripiprazole, Atypical Antipsychotics, Avoidable Harm, Avoidable Hospital Mortality, Avoidable Mortality, Behavioural and Psychological Symptoms of Dementia (BPSD), Benefits and Risks of Antipsychotic Treatment, Betsi Cadwaladr University Health Board, Black Country, Black Country Partnership NHS Foundation Trust, BPSD, BPSD: Behavioral and Psychological Symptoms of Dementia, British Indian Psychiatric Association (BIPA), Community and Mental Health Trusts, Dr Sarmishtha Bhattacharyya: Consultant in Old Age Psychiatry at Wrexham Maelor Hospital, Faculty of Health and Social Care: University of Chester, Geriatric Care and Research Organisation (GeriCaRe), Haloperidol, Improving Prescribing Practice, Inappropriate Prescribing, Inappropriate Use of Antipsychotics in Dementia, Journal of Geriatric Care and Research (JGCR), Learning Disabilities, Medication Reviews, Mental Health Trusts, North Wales, Olanzapine, Over-Medication, Over-Medication for People With Learning Disabilities, Over-Prescribing, Overprescribing, People With Learning Disabilities, Personalised Care Versus Guideline-Based Care, Personalised Medicine Versus Guideline-Based Medicine, Potential Harms of Antipsychotic Use, Potentially Inappropriate Prescribing, Prescribing Anti-Psychotic Drugs to People with Dementia, Prescribing of Antipsychotic Drugs For People With Dementia, Prescribing of Antipsychotic Drugs For People With Learning Disabilities, Psychosis in Patients With Dementia, Quetiapine, Reducing Agitation and Distress, Reducing Antipsychotic Prescriptions in Dementia, Reducing Avoidable Premature Mortality, Reducing Inappropriate Use of Antipsychotics, Reducing Inappropriate Use of Antipsychotics in Dementia, Reducing Violence and Aggression, Risperidone, Safe and Compassionate Care, United States, University of Chester, USA, Violence and Aggression, West Midlands, Wrexham, Wrexham Maelor Hospital, Ziprasidone
|
Leave a comment
Barbican Consensus on Better Care and Support for People With Dementia in Care Homes (NHS England)
Summary It has been reported elsewhere that 80% of residents in care homes may have dementia, and that there may still be over-prescription of antipsychotics in these settings to control challenging behaviour. The Barbican Consensus presents a general agreement, arrived … Continue reading →
Posted in Acute Hospitals, Alzheimer's Society, Antipsychotics, BBC News, Commissioning, Community Care, CQC: Care Quality Commission, Department of Health, Diagnosis, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), In the News, Integrated Care, Local Interest, Management of Condition, Mental Health, Models of Dementia Care, National, NHS, NHS England, Non-Pharmacological Treatments, Patient Care Pathway, Person-Centred Care, Pharmacological Treatments, Practical Advice, Quick Insights, SCIE, Standards, Telecare, Telehealth, UK, Universal Interest
|
Tagged 5YFV: NHS Five Year Forward View, Activity Levels Among People With Dementia in Care Homes, Airedale NHS Foundation, Alistair Burns, Alistair Burns: NHS England’s National Clinical Director for Dementia, Alistair Burns: NHS England’s National Clinical Director for Older People’s Mental Health, Alternatives to Antipsychotic Drugs, Alternatives to Medication for Agitation, Antipsychotic Prescribing in Care Homes, Antipsychotic Prescribing in Nursing Homes in the United States, Antipsychotics Limitation in Dementia, Antipsychotics-Related Mortality Risks, Barbican Consensus: Care and Support for People With Dementia in Care Homes, BBC Health News, BBC Radio Four File on 4, Built Environment, Care and Compassion, Care and Support for People With Dementia in Care Homes, Care England, Care Integration, Care Planning, Care Staff Education, Challenge on Dementia 2020, Collaborative Care Planning, Commissioning for Maximum Value, Commissioning for Older People, Commissioning for Outcomes, Commissioning for Quality, Commissioning for Transformation, Community Mental Health, Community Mental Health Services, Community Nursing, Compassion in Care, Compassionate Care, Conditions for Integration, Coordinated Care, Cracks in the Pathway (CQC), Culture of Compassionate Care, Dementia Challenge, Dementia In-Reach Teams, Dementia Primer for General Practice, Dementia Revealed: Dementia Guide for GPs, Dementia Toolkit for GP Commissioners, Dementia Toolkit for GPs, Dementia-Friendly Environmental Design, Dementia: People With Dementia in Care Homes, Design and Built Environment, Dignity, Dignity and Respect, Dignity in Care, Discontinuation of Antipsychotics, Dr Nick Cartmell: Clinical Advisor for Dementia in the South, East and North Hertfordshire CCG, Education and Staff Training, Encouraging Independence and Social Interaction, Enhanced Health in Care Homes, Enhanced Personalised Care Plans, Environmental Design, File on 4 (BBC Radio 4), Five Year Forward View (NHS England), Four Seasons Health Care, In Reach, Integrated Care and Support, Integrated Care for Older People With Complex Needs, Integrated Commissioning, Integrating Health and Social Care Personal Budgets, James Cross: National Lead for Dementia at Skills For Care, Leadership for Compassionate Care, Liaison and In-Reach Services for Frail Older People, Local Integration, Long-Term Care (LTC), Long-Term Care and Support, Long-Term Conditions, Long-Term Conditions (LTCs), Long-Term Health and Social Support, Long-Term Services and Support (LTSS), Long-Term Treatment, Meaningful Activity, Meaningful Activity and Occupation, Medication Reviews, Models of Care: Age-Related Models, Models of Care: Integrated Models, Models of Enhanced Health in Care Homes, Models of Enhanced Health in Care Homes - Vanguard Site: Airedale NHS Foundation, Models of Enhanced Health in Care Homes - Vanguard Site: East and North Hertfordshire CCG, Models of Enhanced Health in Care Homes - Vanguard Site: Newcastle Gateshead Alliance, Models of Enhanced Health in Care Homes - Vanguard Site: NHS Wakefield CCG, Models of Enhanced Health in Care Homes - Vanguard Site: Nottingham City CCG, Models of Enhanced Health in Care Homes - Vanguard Site: Sutton CCG, Models of Enhanced Health in Care Homes Vanguard Sites, National Care Forum, New Care Models: Vanguard Sites, New Models of Care, Newcastle Gateshead Alliance, NHS England, NHS England’s Five Year Forward View, NHS Five Year Forward View (5YFV), NHS Nottingham City CCG, NHS Sutton CCG, NHS Wakefield CCG, Partnership Working, People with Dementia in Care Homes, Personal Budgets (PBs), Post-Diagnosis Support, Post-Diagnostic Dementia Support, Post-Diagnostic Support, Prime Minister’s Challenge On Dementia 2020, Prime Minister’s Dementia Challenge, Proactive Specialist In-Reach, Professor Alistair Burns, Quality Statement 1: Participation in Meaningful Activity, Redesigning Local Healthcare Systems, Redesigning Services, Reducing Inappropriate Use of Antipsychotics, Safe and Compassionate Care, Skills for Care, Social Care Institute for Excellence (SCIE), Staff Education, Staff Training, Statistics on Assaults in Care Homes, Statistics on Challenging Behaviour in Care Homes, Timely Diagnosis, United Kingdom Homecare Association, Workforce Competencies, Workforce Development
|
Leave a comment
Reducing Antipsychotic Prescribing for BPSD (BMJ / JAMA / JAMA Psychiatry / BJCP)
Summary This BMJ “Change page” article discusses the potential harms associated with use of antipsychotics in people with dementia, and covers guidelines recommending restrictions in their use. Risperidone is the antipsychotic recommended for use in the treatment of aggression associated … Continue reading →
Posted in Acute Hospitals, Antipsychotics, Community Care, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), International, Management of Condition, Mental Health, Models of Dementia Care, Non-Pharmacological Treatments, Person-Centred Care, Pharmacological Treatments, Practical Advice, Quick Insights, Standards, Statistics, UK
|
Tagged Adverse Drug Reactions (ADRs), Adverse Drug Reactions (ADRs): Type A (Potentially Avoidable and Associated With Commonly Prescribed Medications), Adverse Drug Reactions in the Elderly, Adverse Effects, Aggression, Aggressive Behaviour, Alternatives to Antipsychotics, Antidepressants, Antihypertensives, Antipsychotic Drugs, Antipsychotics, Antipsychotics and Risk of Venous Thromboembolism, Antipsychotics Limitation in Dementia, Antipsychotics Side Effects, Antipsychotics-Related Mortality Risks, Antipsychotics: Absolute Mortality Risk Increase, Antipsychotics: Neuroleptic Sensitivity, Antipsychotics: Number Needed to Harm (NNH), Atypical Antipsychotics, Behavioural and Psychological Symptoms of Dementia (BPSD), Benzodiazepines, BMJ, BPSD, BPSD: Behavioral and Psychological Symptoms of Dementia, Brief Psychosocial Treatment, British Journal of Clinical Pharmacology, British Medical Journal (BMJ), Campbell Institute (CAMH): University of Toronto, Cardiff University, Center for Clinical Management Research: Veterans Affairs Ann Arbor Healthcare System (Michigan), Center for Statistical Consultation and Research: University of Michigan, CitAD Research Group, Citalopram for Agitation in Alzheimer's Disease: CitAD Trial, Clinical Biotechnology Research Institute: Roper St Francis Healthcare (Charleston: South Carolina), College of Physicians and Surgeons of Columbia University, DART-AD: Dementia Antipsychotic Withdrawal Trial (DART-AD), Dementia Antipsychotic Withdrawal Trial (DART-AD), Department of Psychiatry: University of Michigan, Department of Psychiatry: University of Southern California, Discontinuation of Antipsychotics, Effect of Citalopram on Agitation in Alzheimer Disease (CitAD Randomized Clinical Trial), Falls Prevention, Hotchkiss Brain Institute: University of Calgary, Inappropriate Prescribing, Inappropriate Use of Antipsychotics in Dementia, International Conference on Harmonization, JAMA, JAMA Psychiatry, Johns Hopkins Bayview and Johns Hopkins School of Medicine, Johns Hopkins Bloomberg School of Public Health: Baltimore, Kings College London, Medication Reviews, National Institute for Health Research (NIHR): Mental Health Biomedical Research Centre and Dementia Unit, NEST Approach, Neuroleptic Discontinuation, Neuroleptics, New York State Psychiatric Institute, Patients’ Needs and the Environment Stimulation and Techniques (NEST), Perelman School of Medicine: University of Pennsylvania, Personalised Social Interaction, Pharmacokinetics, Polypharmacy, Potential Harms of Antipsychotic Use, Prescribing Anti-Psychotic Drugs to People with Dementia, Reducing Agitation and Distress, Reducing Antipsychotic Medication in Care Homes, Reducing Antipsychotic Prescriptions in Dementia, Reducing Inappropriate Use of Antipsychotics in Dementia, Reducing Violence and Aggression, Risperidone, Seattle Protocols, Simulated Presence Therapy, South London and Maudsley NHS Foundation Trust, Stanford University School of Medicine, United States, University Hospital Llandough (Cardiff), University of Calgary, University of Manchester, University of Michigan, University of Pennsylvania, University of Rochester School of Medicine and Dentistry, University of Southern California, University of Southern California Keck School of Medicine, University of Toronto, Violence and Aggression, Wolfson Centre for Age-Related Diseases: King’s College London
|
Leave a comment
Reducing Antipsychotic Prescriptions for Dementia in Primary Care (HSJ / NHS London)
Summary The Dementia and Prescribing Antipsychotic Project, run by London-based CCGs, helped to reduce prescribing levels by between 48% and 77%. The project aimed to raise awareness of the risks of antipsychotic prescribing for behavioural and psychological symptoms in dementia. … Continue reading →
Posted in Antipsychotics, Commissioning, Community Care, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), Integrated Care, Management of Condition, Mental Health, Models of Dementia Care, NHS, Non-Pharmacological Treatments, Patient Care Pathway, Patient Information, Person-Centred Care, Pharmacological Treatments, Practical Advice, Quick Insights, Standards, UK, Universal Interest
|
Tagged Antipsychotic Drugs, Antipsychotic Prescribing in Care Homes, Antipsychotic Prescribing in Nursing Homes, Antipsychotics and Risk of Venous Thromboembolism, Antipsychotics Limitation in Dementia, Antipsychotics Side Effects, Antipsychotics-Related Mortality Risks, Antipsychotics: Neuroleptic Sensitivity, Atypical Antipsychotics, Behavioural and Psychological Symptoms of Dementia (BPSD), Bexley, BPSD, BPSD: Behavioral and Psychological Symptoms of Dementia, Bromley, Care Homes, CCGs, Clinical Commissioning Groups (CCGs), Community Care, Community Care Services, Community Pharmacists, Croydon, Dementia and Prescribing Antipsychotic Project, Differemtial Antipsychotic-Related Mortality Risks, Differential Risk of Death (Antipsychotic Drugs), Distressed Behaviour, East and South East Specialist Pharmacy Services, General Practice, GP Clusters, GPs, Guideline on Supporting People with Dementia and Their Carers in Health and Social Care, Guys and St Thomas Foundation Trust, Health Service Journal (HSJ), Home and Community Care Services, HSJ, Inappropriate Use of Antipsychotics in Dementia, Integrated Care Services, Integrated Commissioning, Integration of Pharmacy Into Community Care, Local Commissioning, London Antipsychotics Audit and Reduction Exercise in Primary Care, London GP Practice Audit of Antipsychotic Prescribing to People With Dementia, London Primary Care, Managing Medicines in Care Homes, Managing Psychological and Behavioural Distress in People with Dementia, Medicines Management, Medicines Management Audits, Mental Health Pharmacists, NHS London, NHSL Antipsychotic GP Audit, NICE Clinical Guideline 42. Dementia: Supporting People With Dementia And Their Carers In Health And Social Care, NICE–SCIE Guideline on Supporting People with Dementia and Their Carers in Health and Social Care, Pharmacists, Prescribing Anti-Psychotic Drugs to People with Dementia, Primary Care, Psychological Symptoms of Dementia (BPSD), Quality and Outcomes Framework (QOF), Reducing Agitation and Distress, Reducing Antipsychotic Medication in Care Homes, Reducing Antipsychotic Prescriptions in Dementia, Reducing Inappropriate Use of Antipsychotics in Dementia, Richmond, Supporting People with Dementia and Their Carers in Health and Social Care, Wandsworth
|
Leave a comment